Ron Dagan Selected Research

Conjugate Vaccines

3/2022	Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY).
1/2022	Corrigendum to: Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media.
1/2022	Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance.
1/2022	A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).
1/2022	The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants.
10/2021	Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH).
10/2021	Effectiveness of Pneumococcal Conjugate Vaccines Against Community-acquired Alveolar Pneumonia Attributable to Vaccine-serotype Streptococcus pneumoniae Among Children.
10/2021	Unraveling the Impact of Pneumococcal Conjugate Vaccines on Ambulatory Antibiotic Drug Consumption in Young Children: An Interrupted Time-Series Analysis.
1/2021	A Prospective, Population-based Study to Determine the Incidence and Bacteriology of Bacterial Conjunctivitis in Children <2 Years of Age Following 7-Valent and 13-Valent Pneumococcal Conjugate Vaccine Sequential Implementation.
1/2021	Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ron Dagan Research Topics

Disease

55	Otitis Media 01/2022 - 07/2002
36	Pneumococcal Infections 03/2022 - 01/2003
23	Pneumonia (Pneumonitis) 04/2022 - 01/2003
16	Infections 01/2022 - 03/2003
8	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 07/2003
6	Communicable Diseases (Infectious Diseases) 01/2021 - 06/2010
5	Tetanus 01/2020 - 02/2003
4	COVID-19 08/2022 - 12/2021
3	Pain (Aches) 03/2022 - 10/2021
3	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2021 - 01/2018
3	Whooping Cough (Pertussis) 01/2020 - 09/2004
3	Conjunctivitis 01/2019 - 09/2005
3	Gastroenteritis 05/2016 - 06/2003
3	Hepatitis B 10/2015 - 02/2008
3	Diarrhea 04/2015 - 08/2005
3	Hepatitis A (Hepatitis, Infectious) 04/2008 - 10/2005
3	Diphtheria 02/2008 - 02/2003
2	Pneumococcal Pneumonia 04/2022 - 06/2008
2	Human Influenza (Influenza) 01/2020 - 01/2010
2	Reinfection 01/2016 - 03/2006
2	Intussusception 06/2015 - 03/2008
2	Haemophilus Infections 05/2014 - 04/2006
2	Fever (Fevers) 02/2014 - 08/2004
2	Poliomyelitis (Polio) 02/2008 - 09/2007
2	Anemia 11/2005 - 01/2005
1	Fatigue 03/2022
1	Myocarditis (Carditis) 12/2021
1	Disease Progression 10/2021
1	Zoonoses 01/2021
1	Bacterial Conjunctivitis 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Rhinorrhea 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Cough 01/2020
1	Bronchiolitis 01/2018
1	Meningitis 01/2018
1	Vaccine-Preventable Diseases 01/2016
1	Celiac Disease (Celiac Sprue) 10/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Mastoiditis 10/2014
1	Drug-Related Side Effects and Adverse Reactions 09/2011
1	Bacterial Infections (Bacterial Infection) 03/2010
1	Deafness (Deaf Mutism) 03/2010
1	Lung Diseases (Lung Disease) 01/2010
1	Paramyxoviridae Infections (Parainfluenza) 01/2010

Drug/Important Bio-Agent (IBA)

58	VaccinesIBA 08/2022 - 01/2003
54	Conjugate VaccinesIBA 03/2022 - 01/2003
37	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 01/2003
9	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 10/2021 - 02/2003
4	BNT162 VaccineIBA 08/2022 - 12/2021
4	10-valent pneumococcal conjugate vaccineIBA 01/2021 - 04/2009
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2003
4	Amoxicillin (Wymox)FDA LinkGeneric 02/2014 - 05/2003
4	Pharmaceutical PreparationsIBA 06/2010 - 05/2003
3	Messenger RNA (mRNA)IBA 08/2022 - 12/2003
3	AntigensIBA 01/2021 - 02/2004
3	C-Reactive ProteinIBA 01/2020 - 02/2014
3	Polysaccharides (Glycans)IBA 08/2010 - 02/2003
3	Anti-Infective Agents (Microbicides)IBA 12/2007 - 07/2003
3	Penicillins (Penicillin)FDA Link 01/2007 - 03/2003
2	23-valent pneumococcal capsular polysaccharide vaccineIBA 03/2022 - 10/2021
2	Rotavirus VaccinesIBA 04/2015 - 03/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 06/2003
2	CRM197 (non-toxic variant of diphtheria toxin)IBA 08/2010 - 02/2008
2	AntibodiesIBA 01/2010 - 01/2005
2	Phosphates (Orthophosphate)IBA 02/2008 - 09/2004
2	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 02/2008 - 09/2004
2	Levofloxacin (Levaquin)FDA Link 01/2008 - 12/2006
2	FluoroquinolonesIBA 01/2008 - 05/2004
2	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 08/2005 - 06/2005
2	Gatifloxacin (Zymar)FDA Link 08/2005 - 11/2003
2	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 09/2004 - 02/2004
2	CytokinesIBA 12/2003 - 06/2003
1	MacrolidesIBA 04/2022
1	nirsevimabIBA 01/2022
1	mRNA VaccinesIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	BCG Vaccine FDA Link 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	insulin receptor-related receptor (IRR)IBA 01/2018
1	MonosaccharidesIBA 01/2016
1	phosphoenolpyruvate-protein phosphotransferaseIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	1,3,6,8-pyrene tetrasulfonate (PTSA)IBA 01/2016
1	Pre-S vaccineIBA 10/2015
1	RotaTeqIBA 06/2015
1	RIX4414 vaccineIBA 06/2015
1	ProteomeIBA 01/2015
1	ProcalcitoninIBA 01/2015
1	Immunoglobulins (Immunoglobulin)IBA 07/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Bacterial VaccinesIBA 03/2010
1	Palivizumab FDA Link 01/2010
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2010
1	motavizumab (Numax)IBA 01/2010

Therapy/Procedure

6	Therapeutics 12/2006 - 03/2003
3	Long-Term Care 08/2022 - 01/2022
3	Medical Day Care (Partial Hospitalization) 01/2008 - 03/2004